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Abstract 
Short communication on t(X;9)(q21;p13) 
PAX5/DACH2, with data on clinics, and the genes 
implicated. 
Clinics and pathology 
Disease 
Acute lymphoblastic leukemia (ALL) 
Epidemiology 
Only one case to date, a 4-year old boy with a pre-B 





The t(X;9)(q21;p13) was the sole abnormality. 






391 amino acids; from N-term to C-term, PAX5 
contains: a paired domain (aa: 16-142); an 
octapeptide (aa: 179-186); a partial homeodomain 
(aa: 228-254); a transactivation domain (aa: 304-
359); and an inhibitory domain (aa: 359-391). 
Lineage-specific transcription factor; recognizes the 
concensus recognition sequence 
GNCCANTGAAGCGTGAC, where N is any 
nucleotide. Involved in B-cell differentiation.  
Entry of common lymphoid progenitors into the B 
cell lineage depends on E2A, EBF1, and PAX5; 
activates B-cell specific genes and repress genes 
involved in other lineage commitments.  
Activates the surface cell receptor CD19 and 
repress FLT3.  
Pax5 physically interacts with the RAG1/RAG2 
complex, and removes the inhibitory signal of the 
lysine-9-methylated histone H3, and induces V-to-
DJ rearrangements.  
Genes repressed by PAX5 expression in early B 
cells are restored in their function in mature B cells 
and plasma cells, and PAX5 repressed (Fuxa et al., 
2004; Johnson et al., 2004; Zhang et al., 2006; 





7 splice transcript variants. 
Protein 
599 amino acids and shorter forms; from N-term to 
C-term, contains a Poly-Gly (amino acids (aa) 56-
61), a Dachshund domain motif N (aa 69-155), 
which interact with HDAC3 (histone deacetylase 3, 
5q31), NCOR1 (nuclear receptor corepressor 1, 
17p11.2), and SIX6 (SIX homeobox 6, 14q23.1), a 
Poly-Ala (aa 350-353), a Dachshund Domain motif 
C, which interact with EYA2 (eyes absent homolog 
2 (Drosophila), 20q13.1), and a Coiled coil domain 
(aa 459-554) (Swiss-Prot).  
DACH2 is a transcriptional repressor of MYOG 
(myogenin, 1q32.1).  
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PAX5/DACH2 fusion protein. 
 
PAX3 (paired box gene 3, 2q36.1) and DACH2 
positively regulate each other, and support the 
existence of a PAX3/SIX1/EYA2/LBX1/DACH2 
network in regulating the myogenic differentiation 
program (Mennerich and Braun, 2001; Kardon et 
al., 2002).  
Histone deacetylase (HDAC4) activity, imported 
into the nucleus, suppresses DACH2 gene 
expression in denervated muscle (Tang and 
Goldman, 2006; Cohen et al., 2007).  
DACH2 represses SIX1 (SIX homeobox 1, 
14q23.1), and SIX1 overexpression has been 
described in gliomas.  
DACH1 (13q22) and DACH2 are required for 
Müllerian duct development. DACH2 is abundantly 
expressed in fallopian tubes, and it has been 
implicated in premature ovarian failure syndrome 
(Bione et al., 2004; Suzumori et al., 2007). In 
ovarian cancer, DACH2 is expressed, and a 
significantly reduced overall survival was found for 
tumours expressing high levels of DACH2 in the 
subgroup of serous carcinoma, but not in other 
subgroups (Nodin et al., 2012). 




Fusion of PAX5 exon 5 to DACH2 exon 3. 
Fusion protein 
Description 
587 amino acids. The predicted fusion protein 
contains the DNA binding paired domain of PAX5 
(the 201 N-term aa) and the DACHbox-C of 
DACH2 (the 386 C-term aa). 
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